Literature DB >> 18713563

MS in Latin America.

G Luetic1.   

Abstract

During the last few years, there has been an increasing desire to study and expand current knowledge about the different aspects of Multiple Sclerosis (MS) in Latin America (LATAM). This report analyzes epidemiological data and specific aspects of MS in this region and aims to describe the current situation, based on the very few scientific publications that contain reliable information. Everything seems to indicate that MS in LATAM has some special characteristics that makes it different from what has been described in other areas of the world. Nevertheless, more thorough research has to be carried out in order to obtain conclusive data regarding the behaviour of the disease in LATAM.

Entities:  

Mesh:

Year:  2008        PMID: 18713563

Source DB:  PubMed          Journal:  Int MS J        ISSN: 1352-8963


  4 in total

1.  Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America.

Authors:  Adriana Carrá; Miguel Ángel Macías-Islas; Alberto Alan Gabbai; Jorge Correale; Carlos Bolaña; Eduardo Duriez Sotelo; Juan García Bonitto; Fernando Vergara-Edwards; Darwin Vizcarra-Escobar
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Spinal cord lesions and disability in Hispanics with multiple sclerosis.

Authors:  L Amezcua; A Lerner; K Ledezma; D Conti; M Law; L Weiner; A Langer-Gould
Journal:  J Neurol       Date:  2013-08-03       Impact factor: 4.849

3.  Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.

Authors:  Laura Ordoñez-Boschetti; Roberto Rey; Ana Cruz; Arijit Sinha; Tracy Reynolds; Nadina Frider; Regina Alvarenga
Journal:  Adv Ther       Date:  2015-07-14       Impact factor: 3.845

Review 4.  MS in self-identified Hispanic/Latino individuals living in the US.

Authors:  Lilyana Amezcua; Jorge R Oksenberg; Jacob L McCauley
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.